Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Adding eltrombopag to immunosuppressive treatment with cyclosporine as front-line therapy for moderate aplastic anemia improves trilineage hematologic response: One-year analysis of the randomised, placebo-controlled, double-blind Phase III trial eltrombopag for moderate aplastic anemia (EMAA Trial)

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMichael HeuserFSFlore Sicre-de-FontbruneAMAstrid Marx‐Hofmann

Discussion

Loading...

Member takes

Overview

Randomised trial showed higher trilineage hematologic response in moderate aplastic anemia with eltrombopag and immunosuppressive treatment.

Key Points

  • Hematologic response rate improved significantly with eltrombopag compared to placebo after 24 weeks of treatment.
  • Response rate was 71.4% in the eltrombopag arm versus 42.5% in placebo, indicating enhanced treatment efficacy.
  • Phase III, double-blind, placebo-controlled trial included 85 treatment-naïve patients with moderate aplastic anemia.
  • Eltrombopag significantly improved hematologic response rates, suggesting it should be the preferred treatment for moderate aplastic anemia.

Cite This Study

Heuser et al. (2025) studied this question.

synapsesocial.com/papers/69362f764fa91c937236e36chttps://doi.org/10.1182/blood-2025-980
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Outcomes of eltrombopag combined with immunosuppressive therapy in adults with severe aplastic anemia: A large, propensity-matched retrospective analysis2025
  2. 2A Multicenter, Retrospective Study Comparing Immunosuppressive Therapy Combined with Eltrombopag to Immunosuppressive Therapy Alone as Front-Line Treatment for Pediatric Severe Aplastic Anemia2025 · 2 citations
  3. 3Long-term outcomes of intensive immunosuppressive therapy combined with eltrombopag in patients with severe aplastic anemia2025
  4. 4Rapid initiation of cyclosporine and eltrombopag ahead of definitive treatment decreases autoimmunity and expedites marrow recovery in a prospective phase II trial2025 · 1 citations
  5. 5Initiating Eltrombopag (EPAG) Early for aplastic Anemia (AA) may Lead to greater clinical benefits: A systematic review and meta-analysis2025